Emphysema and carbonmonoxide diffusion capacity in male chronic obstructive pulmonary disease patients

E. Bulcun, M. Arslan, A. Ekici, E. Sentürk, M. Ekici (Kirikkale, Turkey)

Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution
Session: Imaging of COPD, asthma and emphysema in evolution
Session type: E-Communication Session
Number: 2903
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Bulcun, M. Arslan, A. Ekici, E. Sentürk, M. Ekici (Kirikkale, Turkey). Emphysema and carbonmonoxide diffusion capacity in male chronic obstructive pulmonary disease patients. Eur Respir J 2009; 34: Suppl. 53, 2903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Emphysema contribution to the progression of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 654s
Year: 2006

Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002

Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001

Lung function parameters in obese patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 78s
Year: 2007

Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001



Minimal bronchiectasis in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010

Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


Chronic obstructive pulmonary disease with preserved lung function, severe hypoxemia and emphysema
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013